Highlights Exagen Inc.

Equities

XGN

US30068X1037

Market Closed - Nasdaq Other stock markets 21:00:00 27/06/2024 BST			5-day change	1st Jan Change
1.85 ^USD	-0.54%		-5.61%	-7.04%

05-14	Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating	MT
05-13	Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Earnings Flash (XGN) EXAGEN Reports Q1 Revenue $14.4M, vs. Street Est of $13.1M	05-13	MT
Exagen Inc. Updates Earnings Guidance for the Full Year 2024	05-13	CI
Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-18	CI
Earnings Flash (XGN) EXAGEN Reports Q4 Revenue $13.8M, vs. Street Est of $11.6M	03-18	MT
Exagen Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	03-18	CI
Exagen Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-18	CI
Exagen Inc. Reaffirms Earnings Guidance for the Full Year Ended December 31, 2023	01-07	CI
Exagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Earnings Flash (XGN) EXAGEN Reports Q3 Revenue $13.4M, vs. Street Est of $10.3M	11-13	MT
Exagen Reaches Settlement With US Department of Justice Over Alleged Kickbacks to Promote Lab Test Use	18/10/23	MT
Exagen Reaches Settlement With US Department of Justice Over Alleged Kickbacks to Promote Lab Test Use	17/10/23	MT
Earnings Flash (XGN) EXAGEN Reports Q2 Revenue $14.1M, vs. Street Est of $10.9M	07/08/23	MT
Exagen Inc. Provides Revenue Guidance for the Third Quarter of 2023	07/08/23	CI
Exagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07/08/23	CI
Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Earnings Flash (XGN) EXAGEN Posts Q1 Revenue $11.2M, vs. Street Est of $9.4M	15/05/23	MT
Exagen Inc. Provides Revenue Guidance for the Second Quarter of 2023	15/05/23	CI
Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	20/03/23	CI
Exagen Inc. Revises Revenue Guidance For the First Quarter of 2023	20/03/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Exagen Inc.

Equities

XGN

US30068X1037

Highlights

Filters